Martin Jädersten

6PUBLICATIONS
84CO-AUTHORS
Gene and molecular therapyRespiratory diseasesHaematological tumoursMedical mycologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML.

|Sep 10, 2026
Hospital at home enables safe and efficient outpatient management of intensively treated acute myeloid leukemia.

|May 19, 2025
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Bianca Tesi, Anna Robelius, Berivan Baskin

|Jul 03, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Elsa Bernard, Robert P Hasserjian, Peter L Greenberg

|Jan 17, 2024
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Magnus Tobiasson, Tatjana Pandzic, Johanna Illman

|Mar 15, 2021
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study.

Aldana Rosso, Gunnar Juliusson, Fryderyk Lorenz

Pageof 1

Frequent Collaborators

3 joint publications

Vladimir Lj Lazarevic

3 joint publications

Magnus Tobiasson

2 joint publications

Linda Fogelstrand

2 joint publications

Martin Höglund